EL En S p A : Conference call - FY2023- Financial results - March.15

COMPANY PRESENTATION

CONFERENCE CALL

FY 2023 Financial results

March 15th, 2024

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward- looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward- looking statements. The Company undertakes no obligation about the contents nor to update the forward- looking statements to reflect events or circumstances that may arise after the date hereof.

2

Income Statement - FY 2023

Euro '000	31/12/22	%	31/12/23	%	Var. %
			unaudited
Medical	382.063	56,7%	392.434	56,7%	2,7%
Industrial	291.518	43,3%	299.856	43,3%	2,9%
Revenues	673.581	100,0%	692.290	100,0%	2,8%
Gross margin	249.695	37,1%	261.430	37,8%	4,7%
Operating Expenses	56.250	8,4%	59.436	8,6%	5,7%
Staff espenses	98.194	14,6%	111.129	16,1%	13,2%
EBITDA	95.251	14,1%	90.866	13,1%	-4,6%
Depr., amort., accruals	14.250	2,1%	18.130	2,6%	27,2%
EBIT	81.001	12,0%	72.736	10,5%	-10,2%
Net financ.income(charges)	(1.934)	-0,3%	(1.533)	-0,2%	-20,7%
Other income (expense) net	(79)	0,0%	(69)	0,0%	-12,9%
EBT	78.988	11,7%	71.134	10,3%	-9,9%
Income taxes	19.953	3,0%	21.068	3,0%	5,6%
Minorities	3.925	0,6%	1.827	0,3%	-53,4%
NET INCOME	55.111	8,2%	48.239	7,0%	-12,5%

3

Income Statement - Q4 2023

Euro '000	Q4-2022	%	Q4-2023	%	Var. %
	unaudited		unaudited
Revenues	189.232	100,0%	199.278	100,0%	5,3%
Gross margin	70.199	37,1%	74.219	37,2%	5,7%
Operating Expenses	14.739	7,8%	15.043	7,5%	2,1%
Staff espenses	27.773	14,7%	30.191	15,2%	8,7%
EBITDA	27.687	14,6%	28.985	14,5%	4,7%
Depr., amort., accruals	4.610	2,4%	8.028	4,0%	74,1%
EBIT	23.077	12,2%	20.958	10,5%	-9,2%
Net financ.income(charges)	(1.927)	-1,0%	(667)	-0,3%	-65,4%
Other income (expense) net	(81)	0,0%	(26)	0,0%	-67,4%
EBT	21.069	11,1%	20.264	10,2%	-3,8%

4

Balance sheet - 2023

Euro '000	31/12/22	31/12/23	Var.%
	restated	unaudited
Total non current assets	165.786	166.200	0,2%
Net Working Capital	200.536	230.449	14,9%
Other receivables/payables ST	(80.154)	(54.244)	-32,3%
Net financial position	75.363	54.586	-27,6%
Long term liabilities	18.077	21.533	19,1%
Net Equity	343.455	375.458	9,3%
Net capital employed	268.092	320.872	19,7%

Net Working Capital on sales	29,8%	33,3%
ROCE	30,2%	22,7%
(EBIT/Net capital employed)
Operating Capex	28.514	13.546

5

Cash Flow

34 mln

25 mln

13 mln

19 mln

6

Revenue breakdown by business

Medical: +3%	-5%		2022

2023

238,8	226,0			+25%				+10%
						+1%
				77,2		15,9	63,9	70,1
			61,9	15,7
Aesthetic	Surgical	Physioth.	Service

+0%

2022

in Euro million

2023

243,8	242,6
				+22%			+15%
							Industrial: +3%
			25,4	31,1		+33%	20,4
					3,9	5,2	17,7
Cutting	Marking	Laser sources	Service	7

Revenue breakdown by area

+3%

Medical		2022

in Euro million

2023

+4%

-2%

230,5 237,2

113,2 117,7

38,4 37,5

Italy

RoEU

RoW

-1%

Industrial +2% 2022

2023

+25%

148,4 146,3

111,6 114,2

31,5 39,3

Italy	RoEU	RoW	8

2024 Guidance

Revenue 2024 > Revenue 2023

EBIT 2024 > EBIT 2023

9

CONTACTS

El.En. S.P.A.

Enrico Romagnoli

Investor Relations Manager

tel. [phone]E-mail:[e-mail]

POLYTEMS HIR

Financial Communication, IR and Press Office

Bianca Fersini Mastelloni - [e-mail]

Silvia Marongiu - [e-mail]

Tel. [phone]